Cipher Pharmaceuticals, Inc. (CPH.TO)
13.39
-0.26
(-1.90%)
CAD |
TSX |
Oct 23, 16:00
Cipher Pharmaceuticals Max Drawdown (5Y) : 72.28% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 72.28% |
| August 31, 2026 | 72.28% |
| July 31, 2026 | 77.61% |
| June 30, 2026 | 78.97% |
| May 31, 2026 | 82.18% |
| April 30, 2026 | 83.71% |
| March 31, 2026 | 84.34% |
| February 28, 2026 | 89.18% |
| January 31, 2026 | 89.18% |
| December 31, 2025 | 89.80% |
| November 30, 2025 | 89.80% |
| October 31, 2025 | 89.80% |
| September 30, 2025 | 89.80% |
| August 31, 2025 | 89.80% |
| July 31, 2025 | 89.80% |
| June 30, 2025 | 90.91% |
| May 31, 2025 | 91.22% |
| April 30, 2025 | 93.53% |
| March 31, 2025 | 95.66% |
| February 28, 2025 | 97.40% |
| January 31, 2025 | 97.40% |
| December 31, 2024 | 97.40% |
| November 30, 2024 | 97.40% |
| October 31, 2024 | 97.40% |
| September 30, 2024 | 97.40% |
| Date | Value |
|---|---|
| August 31, 2024 | 97.40% |
| July 31, 2024 | 97.40% |
| June 30, 2024 | 97.40% |
| May 31, 2024 | 97.40% |
| April 30, 2024 | 97.40% |
| March 31, 2024 | 97.40% |
| February 29, 2024 | 97.40% |
| January 31, 2024 | 97.40% |
| December 31, 2023 | 97.40% |
| November 30, 2023 | 97.40% |
| October 31, 2023 | 97.40% |
| September 30, 2023 | 97.40% |
| August 31, 2023 | 97.40% |
| July 31, 2023 | 97.40% |
| June 30, 2023 | 97.40% |
| May 31, 2023 | 97.40% |
| April 30, 2023 | 97.40% |
| March 31, 2023 | 97.40% |
| February 28, 2023 | 97.40% |
| January 31, 2023 | 97.40% |
| December 31, 2022 | 97.40% |
| November 30, 2022 | 97.40% |
| October 31, 2022 | 97.40% |
| September 30, 2022 | 97.40% |
| August 31, 2022 | 97.40% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| HLS Therapeutics, Inc. | 87.57% |
| Bausch Health Cos., Inc. | 87.23% |
| BioSyent, Inc. | 37.15% |
| Revive Therapeutics Ltd. | 99.36% |
| Knight Therapeutics, Inc. | 52.84% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 34.28 |
| Beta (5Y) | 0.5262 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 53.83% |
| Historical Sharpe Ratio (5Y) | 0.7457 |
| Historical Sortino (5Y) | 1.792 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 13.21% |